PROSPERI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 26.541
EU - Europa 19.104
AS - Asia 11.994
SA - Sud America 1.794
AF - Africa 323
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 21
Totale 59.806
Nazione #
US - Stati Uniti d'America 25.856
SE - Svezia 6.625
SG - Singapore 3.924
IT - Italia 3.589
DE - Germania 2.680
CN - Cina 2.653
VN - Vietnam 1.968
HK - Hong Kong 1.419
BR - Brasile 1.371
RU - Federazione Russa 1.318
DK - Danimarca 914
IE - Irlanda 891
GB - Regno Unito 664
UA - Ucraina 541
IN - India 495
CA - Canada 490
FR - Francia 485
PL - Polonia 370
FI - Finlandia 275
AT - Austria 229
KR - Corea 228
ID - Indonesia 180
AR - Argentina 158
BD - Bangladesh 157
TR - Turchia 136
MX - Messico 130
IQ - Iraq 128
ES - Italia 124
PK - Pakistan 110
JP - Giappone 103
NL - Olanda 103
ZA - Sudafrica 98
SA - Arabia Saudita 73
PH - Filippine 64
CH - Svizzera 57
EC - Ecuador 56
UZ - Uzbekistan 52
CO - Colombia 51
VE - Venezuela 46
IR - Iran 40
BE - Belgio 39
CZ - Repubblica Ceca 38
KE - Kenya 37
MA - Marocco 36
CL - Cile 31
EG - Egitto 30
PY - Paraguay 30
AE - Emirati Arabi Uniti 24
IL - Israele 24
JO - Giordania 24
MY - Malesia 24
AZ - Azerbaigian 22
AU - Australia 21
ET - Etiopia 18
GR - Grecia 18
LT - Lituania 18
TN - Tunisia 18
EU - Europa 17
UY - Uruguay 17
PE - Perù 16
TW - Taiwan 16
BO - Bolivia 14
PT - Portogallo 14
RO - Romania 14
AL - Albania 13
BG - Bulgaria 13
DZ - Algeria 13
TH - Thailandia 13
CR - Costa Rica 12
HU - Ungheria 12
JM - Giamaica 12
KG - Kirghizistan 11
MU - Mauritius 11
NP - Nepal 11
DO - Repubblica Dominicana 10
LB - Libano 10
NO - Norvegia 10
OM - Oman 10
KZ - Kazakistan 9
LV - Lettonia 9
NG - Nigeria 9
MO - Macao, regione amministrativa speciale della Cina 8
PA - Panama 8
QA - Qatar 8
AO - Angola 7
BY - Bielorussia 7
PS - Palestinian Territory 7
RS - Serbia 7
SC - Seychelles 7
CI - Costa d'Avorio 6
CY - Cipro 6
GA - Gabon 6
NZ - Nuova Zelanda 6
SN - Senegal 6
TT - Trinidad e Tobago 6
GE - Georgia 5
HN - Honduras 5
LU - Lussemburgo 5
MD - Moldavia 5
MM - Myanmar 5
Totale 59.719
Città #
Ann Arbor 7.834
Stockholm 5.615
Singapore 2.256
Frankfurt am Main 2.225
Ashburn 1.819
Woodbridge 1.588
Fairfield 1.435
Hong Kong 1.372
Milan 1.285
San Jose 1.195
Chandler 1.082
Houston 1.030
Dublin 858
Wilmington 840
Jacksonville 553
Seattle 552
New York 515
Dearborn 514
Cambridge 483
Ho Chi Minh City 478
Santa Clara 468
Hanoi 401
Los Angeles 396
Beijing 360
Dallas 352
Chicago 319
Hefei 292
Princeton 290
Kraków 264
The Dalles 220
Nanjing 196
Vienna 193
Shanghai 191
Council Bluffs 186
Dong Ket 185
Seoul 166
Buffalo 148
Lauterbourg 148
Lawrence 144
Toronto 139
Altamura 136
São Paulo 132
Jakarta 122
Guangzhou 114
Munich 107
Helsinki 101
San Diego 90
Moscow 89
Boardman 86
Fremont 86
Lachine 85
Rome 84
London 83
Montréal 77
Warsaw 76
Tokyo 75
Brooklyn 74
Da Nang 74
Orem 74
Haiphong 71
Montreal 63
Chennai 60
Baghdad 57
Nanchang 57
Nuremberg 55
Turku 55
Kent 54
Ottawa 52
Changsha 51
Florence 49
Shenyang 48
Denver 46
Tashkent 46
Pavia 45
Phoenix 45
Johannesburg 44
Tianjin 44
Turin 42
Rio de Janeiro 41
Salt Lake City 41
Monza 40
Mumbai 39
Belo Horizonte 37
Pune 37
Hyderabad 35
Mexico City 35
Poplar 35
Atlanta 34
Desio 34
Hebei 34
Biên Hòa 31
Columbus 31
Zurich 31
Brussels 30
Nairobi 30
Palermo 30
Boston 29
Jinan 29
Amsterdam 28
Kunming 28
Totale 42.075
Nome #
Biomimetic responsive antigen-delivery vehicles for therapeutic and preventive vaccines against hereditary triple-negative breast cancer 1.953
Harnessing Mirror-Image Peptides: Nanoparticle Vectors for Nucleic Acid Delivery 1.931
Nanoparticle-Mediated Laser Ablation: An Integrated Phantom Experimental-Computational Framework for Selective Cancer Therapy 1.910
MnO Nanoparticles Embedded in Functional Polymers as T1 Contrast Agents for Magnetic Resonance Imaging 662
Inositol 1,4,5-trisphosphate 3-kinase B promotes Ca2+mobilization and the inflammatory activity of dendritic cells 646
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 640
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 630
Thirty years of cancer nanomedicine: Success, frustration, and hope 623
Killing cancer cells by targeting the tumor microenvironment: study of TRAIL journey in a CAFs model 615
The emerging role of nanotechnology in skincare 594
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems 593
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 591
Multifunctional Magnetic Gold Nanomaterials for Cancer 571
Functionalization of colloidal nanoparticles with a discrete number of ligands based on a “HALO-bioclick” reaction 559
Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations 552
Are nanotechnological approaches the future of treating inflammatory diseases? 547
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 546
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 544
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 538
Targeted delivery of nanoparticles 536
Monitoring the fate of orally administered plga nanoformulation for local delivery of therapeutic drugs 528
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 521
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax 514
Nanoparticle-Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment 513
Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia 511
Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles 486
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 483
Bioengineered Approaches for Site Orientation of Peptide-Based Ligands of Nanomaterials 475
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer 454
Relaxometric studies of Gd-Chelate conjugated on the surface of differently shaped gold nanoparticles 452
Dynamic molecular exchange and conformational transitions of alpha-synuclein at the nano-bio interface 446
“Blind” targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates 441
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor 441
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages 439
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 437
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 434
A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake 429
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer 429
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies 425
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study 423
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer 414
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer 412
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 408
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 406
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 404
Anti-madcam-1-conjugated nanocarriers delivering quantum dots enable specific imaging of inflammatory bowel disease 404
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 401
Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts 400
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 383
Half-Chain trastuzumab nanoconjugates enhance antitumor activity in HER2+ breast cancer 383
Olaparib nanoformulation in H-Ferritin for the triple negative breast cancer treatment 381
Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells 376
Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles 375
Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes 367
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection 366
Recent advances in magnetic fluid hyperthermia for cancer therapy 365
Preface frontiers in cancer immunotherapy: Understanding the role of gut microbiota 364
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice 364
Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective 351
Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates 351
Loss of exosomes in progranulin-associated frontotemporal dementia 351
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 349
Conjugation of gold nanoparticles with multidentate surfactants for enhanced stability and biological properties 347
Suicide gene therapy: A new frontier for cancer fighting 345
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands 343
Nano-targeting of Mucosal Addressin Cell Adhesion Molecule-1 identifies bowel inflammation foci in murine model 337
Orientation-controlled conjugation of haloalkane dehalogenase fused homing peptides to multifunctional nanoparticles for the specific recognition of cancer cells 333
O6-alkylguanine-DNA transferase (SNAP) as capture module for site-specific covalent bioconjugation of targeting protein on nanoparticles 333
Curcumin Formulations and Trials: What’s New in Neurological Diseases 332
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 331
Dependence of nanoparticle-cell recognition efficiency from surface orientation of scFv targeting ligands 328
Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells 322
Combined mass quantitation and phenotyping of intact extracellular vesicles by a microarray platform 321
Nanoparticle-mediated delivery of suicide genes in cancer therapy 316
Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect 309
Meet our editor-in-chief 308
Development of U11-functionalized gold nanoparticles for selective targeting of urokinase plasminogen activator receptor-positive breast cancer cells 306
MAdCAM-1 nanotargeting uncovers bowel inflammation foci in experimental model of colitis 304
Co-processed materials testing as excipients to produce Orally Disintegrating Tablets (ODT) using binder jet 3D-printing technology 303
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 301
Click Chemistry Immobilization of Antibodies on Polymer Coated Gold Nanoparticles 301
Detection of nanostructures in solutions of Zincum metallicum and the vehicle lactose 301
Microfluidic nanoparticle synthesis for oral solid dosage forms: A step toward clinical transition processes 300
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches 298
Site-Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain-Promoted Alkyne-Nitrone Cycloaddition 298
Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells 289
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells 287
Immobilization of carboxypeptidase from Sulfolobus solfataricus on magnetic nanoparticles improves enzyme stability and functionality in organic media 286
TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness 283
Gold nanocages for imaging and therapy of prostate cancer cells 279
Light scattered by model phantom bacteria reveals molecular interactions at their surface 278
Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases 278
Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2 277
Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer 276
Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cells 276
Eco-luxury: Making sustainable drugs and cosmetics with Prosopis cineraria natural extracts 274
The synthesis of allolactose from amygdalin 274
Intracellular Drug Release from Curcumin-Loaded PLGA Nanoparticles Induces G2/M Block in Breast Cancer Cells 274
Impact of semi-solid formulations on skin penetration of iron oxide nanoparticles 273
Towards ideal magnetofluorescent nanoparticles for bimodal detection of breast-cancer cells 271
Totale 44.929
Categoria #
all - tutte 156.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.347 0 0 0 0 0 0 0 0 0 0 499 848
2021/20225.546 605 587 601 526 334 352 451 410 317 355 390 618
2022/20235.893 745 1.452 720 619 524 793 127 210 372 102 138 91
2023/20242.895 123 86 161 131 350 624 655 96 172 76 82 339
2024/20257.258 371 601 677 364 633 308 484 298 745 1.072 647 1.058
2025/202621.638 2.024 1.015 1.220 1.811 2.040 973 2.703 880 1.535 7.176 261 0
Totale 61.047